Hello JP, I hope I have not offended you. By mentioning the crystal ball I meant that I am not able to predict the future, even though sometimes I wished I could see a bit further than the horizon. Pluristem are a start up company and they need to follow due process before they are in a position to bring their product to market. The pharmaceutical industry is heavily regulated, so everything takes time. I once read that it can take up to 15 years for a new medicine to be approved (including development). It is positive that Pluristem may be able to get fast track approval. I don't think anybody investing in this company will get rich quickly (if at all).
News 
Market Data 
Discover 
